Opioid use in cancer patients compared with noncancer pain patients in a veteran population
JNCI Cancer Spectrum · 29.02.2024 · 8 (2)
DOI: 10.1093/jncics/pkae012 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 08.03.2024. Verfasst von Seshadri C Mudumbai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesiology, Perioperative and Pain Medicine Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA. Hauptthemen laut MEDLINE: Neoplasms, Veterans. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Opioid safety initiatives may secondarily impact opioid prescribing and pain outcomes for cancer care.
Methods
We reviewed electronic health record data at a tertiary Veterans Affairs system (VA Palo Alto) for all patients from 2015 to 2021. We collected outpatient Schedule II opioid prescriptions data and calculated morphine milligram equivalents (MMEs) using Centers for Disease Control and Prevention conversion formulas. To determine the clinical impact of changes in opioid prescription, we used the highest level of pain reported by each patient on the 0-to-10 Numeric Rating Scale in each year, categorized into mild (0-3), moderate (4-6), and severe (7 and above).
Results
Among 89 569 patients, 9073 had a cancer diagnosis. Cancer patients were almost twice as likely to have an opioid prescription compared with noncancer patients (69.0% vs 36.7%, respectively). The proportion of patients who received an opioid prescription decreased from 27.1% to 18.1% (trend P < .01) in cancer patients and from 17.0% to 10.2% in noncancer patients (trend P < .01). Cancer and noncancer patients had similar declines of MMEs per year between 2015 and 2019, but the decline was more rapid for cancer patients (1462.5 to 946.4, 35.3%) compared with noncancer patients (1315.6 to 927.7, 29.5%) from 2019 to 2021. During the study period, the proportion of noncancer patients who experienced severe pain was almost unchanged, whereas it increased among cancer patients, reaching a significantly higher rate than among noncancer patients in 2021 (31.9% vs 27.4%, P < .01).
Conclusions
Our findings suggest potential unintended consequences for cancer care because of efforts to manage opioid-related risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Anesthesiology, Perioperative and Pain Medicine Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
- Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
- Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
ORCID-Profile: Seshadri C Mudumbai, Arash Etemadi
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Mudumbai, S. C., He, H., Chen, J. Q., Kapoor, A., Regala, S., Mariano, E. R., Stafford, R. S., Abnet, C. C., Pfeiffer, R. M., Freedman, N. D., & Etemadi, A. (2024). Opioid use in cancer patients compared with noncancer pain patients in a veteran population. JNCI Cancer Spectrum, 8(2). https://doi.org/10.1093/jncics/pkae012
Vancouver
Mudumbai SC, He H, Chen JQ, Kapoor A, Regala S, Mariano ER, et al. Opioid use in cancer patients compared with noncancer pain patients in a veteran population. JNCI Cancer Spectrum. 2024;8(2). doi:10.1093/jncics/pkae012
BibTeX
@article{Mudumbai2024,
author = {Mudumbai, Seshadri C and He, Han and Chen, Ji-Qing and Kapoor, Aditi and Regala, Samantha and Mariano, Edward R and Stafford, Randall S and Abnet, Christian C and Pfeiffer, Ruth M and Freedman, Neal D and Etemadi, Arash},
title = {Opioid use in cancer patients compared with noncancer pain patients in a veteran population},
journal = {JNCI Cancer Spectrum},
year = {2024},
volume = {8},
number = {2},
doi = {10.1093/jncics/pkae012}
}
EUVIMED